SSI |
Surgical Site Infections |
S. epidermidis
|
Staphylococcus epidermidis
|
S. aureus
|
Staphylococcus aureus
|
P. aeruginosa
|
Pseudomonas aeruginosa
|
E. coli
|
Escherichia coli
|
API |
Active Pharmaceutical Ingredient |
USP |
United States Pharmacopeia |
PBS |
phosphate buffer saline |
PCL |
Polycaprolactone |
SEM |
Scanning electron microscope |
PLLA |
Poly(l-lactic acid) |
PGA |
Polyglycolic acid |
PP |
Polypropylene |
PE |
Polyethylene |
PET |
Polyester |
PDO |
Poly-p-dioxanone |
TCH |
Tetracycline hydrochloride |
ORC |
Oxidative regenerated cellulose |
BCNCCs |
Bacterial cellulose nanocrystals |
RC |
Regenerated chitin |
P3BV-co-HB |
Poly (3-hydroxybutyrate-co-4-hydroxybutyrate) |
EC |
Ethyl cellulose |
PLACL |
Poly(l-lactide-co-ε-caprolactone) |
PLGA |
Poly (lactic-co-glycolic acid) |
FDA |
Food and Drug Administration |
NO |
Nitric oxide |
GO |
Graphene oxide |
VEGF |
Vascular endothelial growth factor |
BFGF |
Fibroblast growth factor |
PEO |
Poly(ethylene oxide) |
COL-HA |
Collagen-hyaluronic acid |